Evidence map›Paper›PMID 40897131›Full record

ReviewEpilepsy & behavior : E&B2025

Depression in older adults with epilepsy: Pathophysiology and management considerations.

Michael Sadek, Zeina Chemali, Rani A Sarkis

Abstract readReview
In one paragraph

Review in Epilepsy & behavior : E&B, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michael SadekDepartment of Neurology, Brigham and Women's Hospital, Harvard Medical School, United States. Electronic address: michael_sadek@hms.harvard.edu.
Zeina ChemaliDepartment of Neurology, Massachusetts General Hospital, Boston, United States; Division of Neuropsychiatry, Massachusetts General Hospital, Boston, United States.
Rani A SarkisDepartment of Neurology, Brigham and Women's Hospital, Harvard Medical School, United States. Electronic address: rsarkis@bwh.harvard.edu.

Funding

The Contribution of Late Onset Unexplained Epilepsy to Cognitive Decline and its Interaction with Vascular and Alzheimer's Disease PathologiesK23NS119798 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI SARKIS, RANI · 2021 to 2025
$1.1M
NINDS NIH HHS K23 NS119798
6 · The paper itself

Abstract

Older adults with epilepsy are at an increased risk for comorbid depression, which worsens their quality of life. This review aims to outline the pathophysiological mechanisms thought to underly the comorbidity of depression in older adults with epilepsy and propose clinical and pharmacological considerations for the holistic management of depression in this population. Indeed, there is a wide range of reported prevalence of depression in older adults with epilepsy, yet these are likely underestimates since depression is underdiagnosed in this population. Age-related drivers of depression include biological and social risk factors such as neurodegenerative changes, inflammation, cerebrovascular dysfunction, social isolation, stigma, and poor health status. Additional contributors related to epilepsy include the impact of seizures, the effects of anti-seizure medications, and the role of sleep-disordered breathing. Therefore, the management of depression in older adults with epilepsy is centered on screening for depression and obstructive sleep apnea, careful choice of anti-seizure medications and anti-depressants, and the provision of social and psychological support.

Indexed as

DepressionEpilepsyAgedAnticonvulsantsComorbidityDisease ManagementHumansQuality of LifeAnticonvulsantsAgingAnti-seizure medicationsDepressionEpilepsyOlder adultsSeizures

Identifiers

PMID40897131
PMCPMC12414575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.